VERACYTE, INC. Basic Shares Outstanding (Weighted Average)
VERACYTE, INC. (VCYT) reported Basic Shares Outstanding (Weighted Average) of 79.97 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-31
- VERACYTE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 79.97M shares, a 2.02% increase year-over-year.
- VERACYTE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 79.54M shares, a 1.93% increase year-over-year.
- VERACYTE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 79.18M shares, a 2.02% increase year-over-year.
- VERACYTE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 78.73M shares, a 2.22% increase year-over-year.
- VERACYTE, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 78.58M shares, a 2.75% increase from fiscal 2024.
- VERACYTE, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 76.48M shares, a 5.29% increase from fiscal 2023.
- VERACYTE, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 72.64M shares, a 1.53% increase from fiscal 2022.
- VERACYTE, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 71.55M shares, a 5.39% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 79.97M shares 10-Q · filed 2026-07-31 | 79.76M shares 10-Q · filed 2026-07-31 | 79.56M shares derived: average of 3 quarters · filed 2026-07-31 | 79.35M shares derived: average of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | 79.54M shares 10-Q · filed 2026-05-06 | 79.36M shares derived: average of 2 quarters · filed 2026-05-06 | 79.15M shares derived: average of 3 quarters · filed 2026-05-06 | 78.96M shares derived: average of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | 79.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 78.95M shares derived: average of 2 quarters · filed 2026-02-26 | 78.77M shares derived: average of 3 quarters · filed 2026-07-31 | 78.58M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 78.73M shares 10-Q · filed 2025-11-05 | 78.56M shares derived: average of 2 quarters · filed 2026-07-31 | 78.38M shares 10-Q · filed 2025-11-05 | 78.19M shares derived: average of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | 78.39M shares 10-Q · filed 2026-07-31 | 78.21M shares 10-Q · filed 2026-07-31 | 78.01M shares derived: average of 3 quarters · filed 2026-07-31 | 77.76M shares derived: average of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | 78.03M shares 10-Q · filed 2026-05-06 | 77.82M shares derived: average of 2 quarters · filed 2026-05-06 | 77.55M shares derived: average of 3 quarters · filed 2026-05-06 | 77.30M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 77.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 77.32M shares derived: average of 2 quarters · filed 2026-02-26 | 77.06M shares derived: average of 3 quarters · filed 2026-02-26 | 76.48M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 77.01M shares 10-Q · filed 2025-11-05 | 76.78M shares derived: average of 2 quarters · filed 2025-11-05 | 76.11M shares 10-Q · filed 2025-11-05 | 75.36M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 76.54M shares 10-Q · filed 2025-08-07 | 75.65M shares 10-Q · filed 2025-08-07 | 74.80M shares derived: average of 3 quarters · filed 2026-02-26 | 74.30M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 74.76M shares 10-Q · filed 2025-05-08 | 73.94M shares derived: average of 2 quarters · filed 2026-02-26 | 73.56M shares derived: average of 3 quarters · filed 2026-02-26 | 73.29M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 73.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 72.96M shares derived: average of 2 quarters · filed 2026-02-26 | 72.80M shares derived: average of 3 quarters · filed 2026-02-26 | 72.64M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 72.80M shares 10-Q · filed 2024-11-07 | 72.64M shares derived: average of 2 quarters · filed 2024-11-07 | 72.49M shares 10-Q · filed 2024-11-07 | 72.32M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 72.48M shares 10-Q · filed 2024-08-07 | 72.33M shares 10-Q · filed 2024-08-07 | 72.16M shares derived: average of 3 quarters · filed 2025-02-28 | 72.03M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 72.18M shares 10-Q · filed 2024-05-08 | 72.00M shares derived: average of 2 quarters · filed 2025-02-28 | 71.89M shares derived: average of 3 quarters · filed 2025-02-28 | 71.78M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 71.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 71.74M shares derived: average of 2 quarters · filed 2025-02-28 | 71.65M shares derived: average of 3 quarters · filed 2025-02-28 | 71.55M shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 71.66M shares 10-Q · filed 2023-11-08 | 71.57M shares derived: average of 2 quarters · filed 2023-11-08 | 71.46M shares 10-Q · filed 2023-11-08 | 71.37M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 71.48M shares 10-Q · filed 2023-08-09 | 71.35M shares 10-Q · filed 2023-08-09 | 71.27M shares derived: average of 3 quarters · filed 2024-02-29 | 70.89M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 71.23M shares 10-Q · filed 2023-05-05 | 71.16M shares derived: average of 2 quarters · filed 2024-02-29 | 70.69M shares derived: average of 3 quarters · filed 2024-02-29 | 69.85M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 71.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 70.42M shares derived: average of 2 quarters · filed 2024-02-29 | 69.39M shares derived: average of 3 quarters · filed 2024-02-29 | 67.89M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 69.74M shares 10-Q · filed 2022-11-03 | 68.53M shares derived: average of 2 quarters · filed 2022-11-03 | 66.82M shares 10-Q · filed 2022-11-03 | 64.61M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 67.32M shares 10-Q · filed 2022-08-03 | 65.33M shares 10-Q · filed 2022-08-03 | 62.90M shares derived: average of 3 quarters · filed 2023-03-01 | 60.89M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 63.33M shares 10-Q · filed 2022-05-04 | 60.70M shares derived: average of 2 quarters · filed 2023-03-01 | 58.75M shares derived: average of 3 quarters · filed 2023-03-01 | 56.62M shares derived: average of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 58.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 56.46M shares derived: average of 2 quarters · filed 2023-03-01 | 54.38M shares derived: average of 3 quarters · filed 2023-03-01 | 53.24M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 54.86M shares 10-Q · filed 2021-11-09 | 52.54M shares derived: average of 2 quarters · filed 2021-11-09 | 51.63M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 50.21M shares 10-Q · filed 2021-07-29 | 50.00M shares 10-Q · filed 2021-07-29 | ||
| 2019-12-31 | 46.14M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |